Names and Identifiers

• • Furo[2,3-h]pyrrolo[3,2,1-jk][1]benzazepin-10(2H)-one,8-ethyldodecahydro-11-methyl-2-[(2S,4S)-tetrahydro-4-methyl-5-oxo-2-furanyl]-,(2S,7aR,8R,8aR,11S,11aR,11bS,11cR)-
  • Neotuberostemonine
  • (2S,7aR,8R,8aR,11S,11aR,11bS,11cR)-8-Ethyl-11-methyl-2-[(2S,4S)-4 -methyl-5-oxotetrahydro-2-furanyl]dodecahydroazepino[3,2,1-hi]fur o[3,2-e]indol-10(2H)-one
  • Furo[2,3-h]pyrrolo[3,2,1-jk][1]benzazepin-10(2H)-one,8-ethyldodecahydro-11-methyl-2-[(2S,4S)-t...
  • Furo[2,3-h]pyrrolo[3,2,1-jk][1]benzazepin-10(2H)-one,8-ethyldodecahydro-11-methyl-2-[(2S,4S)-tetrahydro-4-methyl-5-oxo-2-fura
  • TSLDASIIWAMMQN
  • Tubastatin A
  • Tuberostemonin
  • [ "" ]
  • C22H33NO4
  • W1111
  • 1ST169128
  • (1S,3S,9R,10R,11R,14S,15R,16R)-10-ethyl-14-methyl-3-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadecan-13-one
  • CS-0023550
  • MS-26085
  • DTXSID501316122
  • SCHEMBL19197265
  • CHEMBL479493
  • 143120-46-1
  • AKOS032948153
  • Q27137725
  • E80776
  • HY-N3196
  • CHEBI:69386
  • AC-34908
  • DA-66034
  • (1S,3S,9R,10R,11R,14S,15R,16R)-10-ethyl-14-methyl-3-((2S,4S)-4-methyl-5-oxooxolan-2-yl)-12-oxa-4-azatetracyclo(7.6.1.04,16.011,15)hexadecan-13-one
  • +expand
• • MDL： MFCD17214798
  • Inchi： 1S/C22H33NO4/c1-4-13-14-7-5-6-8-23-16(17-9-11(2)21(24)26-17)10-15(19(14)23)18-12(3)22(25)27-20(13)18/h11-20H,4-10H2,1-3H3/t11-,12-,13+,14+,15-,16-,17-,18-,19+,20+/m0/s1
  • InChI Key： GYOGHROCTSEKDY-UEIGSNQUSA-N
  • SMILES： O1C([C@@]([H])(C([H])([H])[H])[C@]2([H])[C@@]1([H])[C@]([H])(C([H])([H])C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N3[C@]([H])([C@]4([H])C([H])([H])[C@]([H])(C([H])([H])[H])C(=O)O4)C([H])([H])[C@]2([H])[C@]31[H])=O

Computed Properties

Experimental Properties